Zurex Pharma Receives $6,200,000 Series A Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3e091984-7de1-4474-a0cc-92aeb3fea9e4
Date
5/22/2012
Company Name
Zurex Pharma
Mailing Address
2113 Eagle Drive Middleton, WI 53562
Company Description
Zurex Pharma, Inc. is a specialty pharma and medical technology company with a novel antimicrobial technology platform. Our company’s mission is to develop and commercialize a portfolio of new antimicrobial products designed to prevent healthcare acquired infections with a focus on surgical site wounds and catheter-related infections.
Website
http://www.zurex-pharma.com
Transaction Type
Venture Equity
Transaction Amount
$6,200,000
Transaction Round
Series A
Proceeds Purposes
Zurex will use the capital to develop and commercialize a portfolio of innovative antimicrobial products designed to prevent healthcare acquired infections with a focus on surgical site wounds and catheter-related infections.
M&A Terms
Venture Investor
Baird Capital
Venture Investor
Baird Capital
Venture Investor
Wisconsin Investment Partners
Venture Investor
Peak Ridge Capital